Standard Biotools Operating Margin vs. Price To Earning
| LAB Stock | USD 1.94 0.08 3.96% |
Standard Biotools Operating Profit Margin |
|
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.63 | 0.4744 |
|
|
For Standard Biotools profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Standard Biotools to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Standard Biotools utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Standard Biotools's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Standard Biotools over time as well as its relative position and ranking within its peers.
Standard |
Standard Biotools' Revenue Breakdown by Earning Segment
Check out Correlation Analysis.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. If investors know Standard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Standard Biotools listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.558 | Quarterly Revenue Growth (0.14) | Return On Assets (0.15) | Return On Equity (0.37) |
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Standard Biotools' value and its price as these two are different measures arrived at by different means. Investors typically determine if Standard Biotools is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Standard Biotools' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Standard Biotools Price To Earning vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Standard Biotools's current stock value. Our valuation model uses many indicators to compare Standard Biotools value to that of its competitors to determine the firm's financial worth. Standard Biotools is rated fourth overall in operating margin category among its peers. It is rated below average in price to earning category among its peers . At present, Standard Biotools' Operating Profit Margin is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Standard Biotools' earnings, one of the primary drivers of an investment's value.Standard Biotools' Earnings Breakdown by Geography
Standard Price To Earning vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Standard Biotools |
| = | (0.29) % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Standard Biotools |
| = | (2.52) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Standard Price To Earning Comparison
Standard Biotools is currently under evaluation in price to earning category among its peers.
Standard Biotools Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Standard Biotools, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Standard Biotools will eventually generate negative long term returns. The profitability progress is the general direction of Standard Biotools' change in net profit over the period of time. It can combine multiple indicators of Standard Biotools, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -2.2 M | -2.1 M | |
| Operating Income | -76.6 M | -72.8 M | |
| Income Before Tax | -74.2 M | -77.9 M | |
| Total Other Income Expense Net | 2.4 M | 2.5 M | |
| Net Loss | -74.7 M | -78.4 M | |
| Income Tax Expense | 452 K | 474.6 K | |
| Interest Income | 74.1 M | 77.8 M | |
| Net Loss | -171.1 M | -162.5 M | |
| Net Interest Income | -4.7 M | -4.9 M | |
| Net Loss | -75.7 M | -79.5 M | |
| Non Operating Income Net Other | 1.1 M | 1 M | |
| Change To Netincome | 35.3 M | 22.8 M | |
| Net Loss | (0.94) | (0.99) | |
| Income Quality | 0.58 | 0.70 | |
| Net Income Per E B T | 1.01 | 1.08 |
Standard Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Standard Biotools. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Standard Biotools position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Standard Biotools' important profitability drivers and their relationship over time.
Use Standard Biotools in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Standard Biotools position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Standard Biotools will appreciate offsetting losses from the drop in the long position's value.Standard Biotools Pair Trading
Standard Biotools Pair Trading Analysis
The ability to find closely correlated positions to Standard Biotools could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Standard Biotools when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Standard Biotools - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Standard Biotools to buy it.
The correlation of Standard Biotools is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Standard Biotools moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Standard Biotools moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Standard Biotools can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Standard Biotools position
In addition to having Standard Biotools in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Index Thematic Idea Now
Macroaxis Index
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. For information on how to trade Standard Stock refer to our How to Trade Standard Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
To fully project Standard Biotools' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Standard Biotools at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Standard Biotools' income statement, its balance sheet, and the statement of cash flows.